{"DataElement":{"publicId":"7712211","version":"1","preferredName":"Head and Neck Cutaneous Squamous Cell Cancer AJCC Edition 8 Group Stage","preferredDefinition":"Stage group based on the combination of T, N, and M categories and relevant prognostic factors for head and neck cutaneous squamous cell carcinoma, using AJCC Ed. 8 criteria.","longName":"HNCSC_AJC8_DZ_STG","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"7708606","version":"1","preferredName":"Head and Neck Neoplasm Stage Grouping Stage","preferredDefinition":"For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas._A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers._The extent of a cancer in the body.","longName":"2228482v1.0:3377203v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2228482","version":"1","preferredName":"Head and Neck Neoplasm","preferredDefinition":"For oncology, area of the body generally construed to comprise base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12418:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Head and Neck","conceptCode":"C12418","definition":"For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6EF4E2B-72AC-72C1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-12","modifiedBy":"ONEDATA","dateModified":"2005-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3377203","version":"1","preferredName":"Stage Grouping Stage","preferredDefinition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8A0D768-D501-B646-E040-BB89AD435C86","latestVersionIndicator":"Yes","beginDate":"2012-02-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-02-10","modifiedBy":"ONEDATA","dateModified":"2012-02-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C56F18FD-BCF4-6C41-E053-4EBD850A14A8","latestVersionIndicator":"Yes","beginDate":"2021-06-23","endDate":null,"createdBy":"TAYLORT","dateCreated":"2021-06-23","modifiedBy":"TAYLORT","dateModified":"2021-06-29","changeDescription":"TL created for AJCC8.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7712202","version":"1","preferredName":"Head and Neck Cutaneous Squamous Cell Carcinoma American Joint Committee on Cancer Edition 8 Group Stage","preferredDefinition":"A term that refers to the staging of cutaneous squamous cell carcinoma of the head and neck according to the American Joint Committee on Cancer, 8th edition._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"7712202v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"3","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"IV","valueDescription":"Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","ValueMeaning":{"publicId":"7652637","version":"1","preferredName":"Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","longName":"7652637","preferredDefinition":"Stage IV includes: (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (Any T, N3, M0); (T4, Any N, M0); (Any T, Any N, M1). T1: Tumor smaller than 2 cm in greatest dimension. T2: Tumor 2 cm or larger, but smaller than 4 cm in greatest dimension. T3: Tumor 4 cm or larger in greatest dimension or minor bone erosion or perineural invasion or deep invasion. Deep invasion is defined as invasion beyond the subcutaneous fat or larger than 6 mm; perineural invasion for T3 classification is defined as tumor cells within the nerve sheath of a nerve lying deeper than the dermis or measuring 0.1 mm or larger in caliber, or presenting with clinical or radiographic involvement of named nerves without skull base invasion or transgression. T4: Tumor with gross cortical bone/marrow, skull base invasion and/or skull base foramen invasion. N2: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(+); or metastasis in a single ipsilateral lymph node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-); or metastases in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-).  N3: Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-); or metastasis in a single ipsilateral lymph node larger than 3 cm in greatest dimension and ENE(+); or metastases in multiple ipsilateral, contralateral, or bilateral lymph nodes, any with ENE(+). M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","conceptCode":"C133259","definition":"Stage IV includes: (T1, N2, M0); (T2, N2, M0); (T3, N2, M0); (Any T, N3, M0); (T4, Any N, M0); (Any T, Any N, M1). T1: Tumor smaller than 2 cm in greatest dimension. T2: Tumor 2 cm or larger, but smaller than 4 cm in greatest dimension. T3: Tumor 4 cm or larger in greatest dimension or minor bone erosion or perineural invasion or deep invasion. Deep invasion is defined as invasion beyond the subcutaneous fat or larger than 6 mm; perineural invasion for T3 classification is defined as tumor cells within the nerve sheath of a nerve lying deeper than the dermis or measuring 0.1 mm or larger in caliber, or presenting with clinical or radiographic involvement of named nerves without skull base invasion or transgression. T4: Tumor with gross cortical bone/marrow, skull base invasion and/or skull base foramen invasion. N2: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(+); or metastasis in a single ipsilateral lymph node larger than 3 cm but not larger than 6 cm in greatest dimension and ENE(-); or metastases in multiple ipsilateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-); or metastases in bilateral or contralateral lymph nodes, none larger than 6 cm in greatest dimension and ENE(-).  N3: Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(-); or metastasis in a single ipsilateral lymph node larger than 3 cm in greatest dimension and ENE(+); or metastases in multiple ipsilateral, contralateral, or bilateral lymph nodes, any with ENE(+). M0: No distant metastasis. M1: Distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BF4166-1611-2EBF-E053-4EBD850A39D0","latestVersionIndicator":"Yes","beginDate":"2021-05-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-07","modifiedBy":"ONEDATA","dateModified":"2021-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C582C449-3E28-0D3D-E053-4EBD850AEA62","beginDate":"2021-06-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-06-24","modifiedBy":"ONEDATA","dateModified":"2021-06-24","deletedIndicator":"No"},{"value":"III","valueDescription":"Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","ValueMeaning":{"publicId":"7652639","version":"1","preferredName":"Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","longName":"7652639","preferredDefinition":"Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor 4 cm or larger in greatest dimension or minor bone erosion or perineural invasion or deep invasion. Deep invasion is defined as invasion beyond the subcutaneous fat or larger than 6 mm; perineural invasion for T3 classification is defined as tumor cells within the nerve sheath of a nerve lying deeper than the dermis or measuring 0.1 mm or larger in caliber, or presenting with clinical or radiographic involvement of named nerves without skull base invasion or transgression. T1: Tumor smaller than 2 cm in greatest dimension.  T2: Tumor 2 cm or larger, but smaller than 4 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(-). M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","conceptCode":"C133258","definition":"Stage III includes: (T3, N0, M0); (T1, N1, M0); (T2, N1, M0); (T3, N1, M0). T3: Tumor 4 cm or larger in greatest dimension or minor bone erosion or perineural invasion or deep invasion. Deep invasion is defined as invasion beyond the subcutaneous fat or larger than 6 mm; perineural invasion for T3 classification is defined as tumor cells within the nerve sheath of a nerve lying deeper than the dermis or measuring 0.1 mm or larger in caliber, or presenting with clinical or radiographic involvement of named nerves without skull base invasion or transgression. T1: Tumor smaller than 2 cm in greatest dimension.  T2: Tumor 2 cm or larger, but smaller than 4 cm in greatest dimension. N0: No regional lymph node metastasis. N1: Metastasis in a single ipsilateral lymph node, 3 cm or smaller in greatest dimension and ENE(-). M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BF4166-1637-2EBF-E053-4EBD850A39D0","latestVersionIndicator":"Yes","beginDate":"2021-05-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-07","modifiedBy":"ONEDATA","dateModified":"2021-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C582C449-3E3D-0D3D-E053-4EBD850AEA62","beginDate":"2021-06-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-06-24","modifiedBy":"ONEDATA","dateModified":"2021-06-24","deletedIndicator":"No"},{"value":"II","valueDescription":"Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","ValueMeaning":{"publicId":"7652641","version":"1","preferredName":"Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","longName":"7652641","preferredDefinition":"Stage II includes: T2, N0, M0. T2: Tumor 2 cm or larger, but smaller than 4 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","conceptCode":"C133257","definition":"Stage II includes: T2, N0, M0. T2: Tumor 2 cm or larger, but smaller than 4 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1BF4166-165D-2EBF-E053-4EBD850A39D0","latestVersionIndicator":"Yes","beginDate":"2021-05-07","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-07","modifiedBy":"ONEDATA","dateModified":"2021-05-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C582C449-3E52-0D3D-E053-4EBD850AEA62","beginDate":"2021-06-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-06-24","modifiedBy":"ONEDATA","dateModified":"2021-06-24","deletedIndicator":"No"},{"value":"I","valueDescription":"Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","ValueMeaning":{"publicId":"7711329","version":"1","preferredName":"Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","longName":"7711329","preferredDefinition":"Stage I includes: T1, N0, M0. T1: Tumor smaller than 2 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","conceptCode":"C133256","definition":"Stage I includes: T1, N0, M0. T1: Tumor smaller than 2 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C57654EE-42CD-7FB9-E053-4EBD850AD954","latestVersionIndicator":"Yes","beginDate":"2021-06-23","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-06-23","modifiedBy":"ONEDATA","dateModified":"2021-06-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C582C449-3E67-0D3D-E053-4EBD850AEA62","beginDate":"2021-06-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-06-24","modifiedBy":"ONEDATA","dateModified":"2021-06-24","deletedIndicator":"No"},{"value":"0","valueDescription":"Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","ValueMeaning":{"publicId":"7712204","version":"1","preferredName":"Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","longName":"7712204","preferredDefinition":"Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8","conceptCode":"C133255","definition":"Stage 0 includes: Tis, N0, M0. Tis: Carcinoma in situ. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C582C449-3E75-0D3D-E053-4EBD850AEA62","latestVersionIndicator":"Yes","beginDate":"2021-06-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-06-24","modifiedBy":"ONEDATA","dateModified":"2021-06-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C582C449-3E8E-0D3D-E053-4EBD850AEA62","beginDate":"2021-06-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-06-24","modifiedBy":"ONEDATA","dateModified":"2021-06-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7712201","version":"1","preferredName":"Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage American Joint Committee on Cancer Stage Grouping Stage","preferredDefinition":"A term that refers to the staging of cutaneous squamous cell carcinoma of the head and neck according to the American Joint Committee on Cancer, 8th edition.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C133253:C39315:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cutaneous Squamous Cell Carcinoma of the Head and Neck by AJCC v8 Stage","conceptCode":"C133253","definition":"A term that refers to the staging of cutaneous squamous cell carcinoma of the head and neck according to the American Joint Committee on Cancer, 8th edition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C582C449-3DF5-0D3D-E053-4EBD850AEA62","latestVersionIndicator":"Yes","beginDate":"2021-06-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-06-24","modifiedBy":"ONEDATA","dateModified":"2021-06-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C582C449-3E06-0D3D-E053-4EBD850AEA62","latestVersionIndicator":"Yes","beginDate":"2021-06-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-06-24","modifiedBy":"TAYLORT","dateModified":"2021-06-29","changeDescription":"6/29/21 TL released.  AK created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"},{"publicId":"10000504","version":"1","longName":"Head and Neck","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Disease stage","type":"Preferred Question Text","description":"Disease stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"C582C449-3FBA-0D3D-E053-4EBD850AEA62","latestVersionIndicator":"Yes","beginDate":"2021-06-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2021-06-24","modifiedBy":"TAYLORT","dateModified":"2021-06-29","changeDescription":"6/29/21 TL released.; AK created for standardization.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}